Drug Database
Back to search

Ireland· IE-PA-EU/1/21/1618/001

Nuvaxovid dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted)

A covid-19, rna-based vaccine product containing sars-cov-2 spike protein recombinant, registered in Ireland by Sanofi Winthrop Industrie. The same ATC class is registered in 11 of our 19 countries.

ATC J07BN01

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedNuvaxovid dispersion for injection CO…ATCJ07BN01REGISTER NO.IE-PA-EU/1/21/1618/001PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about sars-cov-2 spike protein recombinantAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Covid-19, rna-based vaccine is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BN01 (covid-19, rna-based vaccine), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 7 of them publish a price we can compare per daily dose
Search covid-19, rna-based vaccine products by name

Covid-19, rna-based vaccine · ATC J07BN01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
SARS-CoV-2 spike protein recombinant
Manufacturer
Sanofi Winthrop Industrie
Country
Ireland (IE)
ATC code
J07BN01
ATC class
Covid-19, RNA-based vaccine
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/21/1618/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under J07BN01

Covid-19, rna-based vaccine, as other registers publish it.

All covid-19, rna-based vaccine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e6c05690-902a-4a62-86b1-c6b677ae0f8a
GET /v1/drugs/e6c05690-902a-4a62-86b1-c6b677ae0f8a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Dispersion for injection",
  "routes": [
    "Intramuscular use"
  ],
  "source": "hpra",
  "atc_all": [
    "J07BN01"
  ],
  "strength": null,
  "pa_number": "EU/1/21/1618/001",
  "substances": [
    "SARS-CoV-2 spike protein recombinant"
  ],
  "legal_basis": "New active substance (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "20/12/2021",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}
API referenceMCP serverPlans

See everything about covid-19, rna-based vaccine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console